Approval · Notice of Compliance 17914 · 2016
ACID REDUCER: Notice of Compliance 17914
Issued March 21, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17914
- Date
- March 21, 2016
- Company
- Laboratoire Riva Inc.Blainville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- ZANTAC (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACID REDUCER | 02452464 | Cancelled Post Market |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB